EQT is in advanced talks to buy testing firm Qiagen
EQT•EQT is in advanced talks to buy Qiagen and has submitted a binding offer of more than $50 a share, reportedly.
1. Binding offer
EQT is in advanced talks to buy testing firm Qiagen and has submitted a binding offer of more than $50 a share.




